Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Roche Diagnostics, Becton Dickinson, Others Receive FDA Clearances in September

Roche Diagnostics, Becton Dickinson, Others Receive FDA Clearances in September

Oct 10, 2018
|
staff reporter

NEW YORK (360Dx) – Roche Diagnostics, Abbott, Siemens Healthineers, and Becton Dickinson were among the companies that received US Food and Drug Administration clearances in September for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. BD Gets CE-IVD Mark for Point-of-Care Coronavirus Antigen Test

  2. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  3. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  4. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark

  5. Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.